These findings not only confirmed the conclusions obtained in our previous study, which indicated that the high expression of NLRP3 signaling pathway-related factors affects the progression of mouse myopia, but also demonstrated that in FDM mice, MCC950 could influence the progression of myopia by inhibiting the expression of the NLRP3 signaling pathway. The gene discussed is NLRP3; the disease is myopia.